Karen Williams

Dr. Karen J. Williams is an innovative and dynamic leader with over three decades of experience in clinical research and drug development within the pharmaceutical and CRO industries. Her exceptional expertise encompasses oncology clinical research, business development, and strategic planning. Dr. Williams has personally managed more than 100 oncology clinical trials, spanning phases I to III, across a wide range of tumor types, both solid and hematological malignancies. Her therapeutic approach expertise includes cell therapy, CAR-T, cytotoxic agents, selective internal radiation, and monoclonal antibodies. Her pharmaceutical experience includes Boehringer Mannheim (now Roche), Novartis Oncology and Pfizer Oncology. In 2012, she established Karma Oncology to provide clinical development services to biotech companies.